WASHINGTON (AP) - A panel of federal health advisers voted Wednesday to recommend approval for an experimental drug to treat Lou Gehrig's disease, a remarkable turnaround for the much-debated medication that was previously rejected by the same group.
#years #development #investigation #significantly #family-members #massachusetts #reliability #johns-hopkins-university
[
add
]
[
|
|
...
]